Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

Shanghai Hengrui Pharmaceutical Co., Ltd., established on 2001-12-04, The scope of business includes the production of nasal sprays,small volume injection,Freeze-dried powder injection,inhalant,Sell ​​self-produced products,Research and develop new pharmaceutical products. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

HJ FUture consists of an international scientific research center, an innovative product development center and a strategic investment cooperation center. A complete R&D chain covering clinical needs analysis, drug design, drug quality control, in vitro and in vivo evaluation, new formulation research, preparation research, and industrial development has been established.

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Shanghai Tianci Biological Valley Bioengineering Co., Ltd., established on 2011-10-21, Business scope includes licensed projects:Class III medical device business;food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Biotechnology,Technology development in the field of medical technology,technical consulting,technology transfer,Technical Services,new drug,food,Biological product,R&D of medical devices,Technical Advisory Services,the first sort,Class II medical device operation,laboratory reagent(In addition to dangerous goods),Anti-labor supplies,Sales of knitted textiles,Own Equipment Rental,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

Liaoning Sibaide Pharmaceutical Technology Co., Ltd., established on 2007-02-09, Business scope includes pharmaceutical products,Biological Products and Preparations,Health products,cosmetic,Cleaning Products,Technology development of medical devices,technology transfer,technical consulting;Market research and information consulting services;Promotion of medical technology;Enterprise Marketing Planning;marketing planning;Business Management Consulting;Conference and exhibition service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Shanghai Zhaoyu Pharmaceutical Technology Co., Ltd., established on 2017-08-15, Business scope includes research and development of biopharmaceutical products,And provide related technology development,technical consulting,Technical Services,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Chengdu Suncadia Pharmaceuticals Co., Ltd. is a Chinese company located in Chengdu. The firm engages in research and development of generic drugs.

Ellipses Pharma is a drug development business specializing in the creation of novel cancer drugs and therapies. Ellipses invests in cancer assets, not companies. Its goal is to bring these exceptional assets into the clinic as soon as possible in order to create more possibilities, run more studies, and save more lives.

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

Shenyang Xinma Pharmaceutical Co., Ltd., established on 1998-11-09, Business scope includes licensed projects:pharmaceutical production,Health food production,Cosmetic production,food production,Production of Class II Medical Devices,Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Manufacturing of daily necessities,Production of Class I Medical Devices,Engineering and Technology Research and Experimental Development,Household Appliance Manufacturing,market survey,Information Consulting Service(Not including licensing information consulting services),Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,marketing planning,Conference and Exhibition Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dacheng Biochemical Technology (Songyuan) Co., Ltd., established on 2005-03-17, The business scope includes the production of amino acid series products#(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Kangzheng Biomedical Co., Ltd., established on 2009-09-23, Business scope includes drugs,Chinese patent medicine,preparation,Pharmaceutical Intermediates,Research and development of fine chemical products,Technology transfer and related technical services;Healthy food,In vitro diagnostic reagents,Molecular Biology Reagents,biomedical materials,R&D of medical devices,Technology transfer and related technical services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhengzhou Taiji Hongnuo Pharmaceutical Co., Ltd., established on 2007-11-26, Business scope includes new drugs,medical instruments,Health products,Technology development of pharmaceutical intermediates,Transfers and Services.

Tianjin Hengrui Pharmaceutical Co., Ltd., established on 2020-11-26, Business scope includes licensed projects:Occupational Health Technical Services;Drug import and export;pharmaceutical production;Pharmaceutical commissioned production;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:R&D and application of cell technology;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shanghai Bangyao Biotechnology Co., Ltd., established on 2013-09-11, The scope of business includes engaging in biotechnology,Technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,Laboratory equipment and consumables,Instrumentation,Class I medical device,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Equipment(Except special equipment),Sales of Electronics,Engaged in the import and export of goods and technology,software development,for-profit medical institution,pharmaceutical production. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of Huapont Life Sciences Co., Ltd., Xizang Linzhi Parkson Pharmaceutical Co. Ltd. is a Chinese company located in Nyingchi that manufactures pharmaceutical products. It was acquired by Huapont Life Sciences Co., Ltd. on January 07, 2015 for $232.57 million.